Yayoi Tada (Y Tada)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 53

Top Topics

Atopic Dermatitis

Top Venues

The Journal of dermatology

Dermatology and therapy

Journal of the European Academy of Dermatology and Venereology : JEADV

The British journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Yukari Okubo, Tadashi Terui, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Takeshi Kimura, Junichiro Shimauchi, Wendy Zhang, Hamid Amouzadeh, Masamoto Murakami
Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study. Dermatology and therapy 14 (7) (2024)
Yayoi Tada, Yukako Sugiura, Manami Kamishima, Yoshihito Tanaka, Hiroaki Tsuchiya, Junya Masuda, Keiichi Yamanaka
Safety and effectiveness of guselkumab in Japanese patients with psoriasis: 20-week interim analysis of a postmarketing surveillance study. The Journal of dermatology (2024)
Yayoi Tada, Ahmed M Soliman, Kanako Ishii, Ryuta Sakuma, Andreas Pinter, Matthew Davis, Dominic Nunag, Marric Buessing, Luis Puig, Shinichi Imafuku
Dose escalation of biologic treatment in patients with moderate-to-severe psoriasis in Japan. Experimental dermatology 33 (5) (2024)
Yayoi Tada, Yukako Sugiura, Manami Kamishima, Yoshihito Tanaka, Hiroaki Tsuchiya, Junya Masuda, Keiichi Yamanaka
Safety and effectiveness of guselkumab in Japanese patients with psoriasis: 20-week interim analysis of a postmarketing surveillance study. The Journal of dermatology 51 (6) (2024)
Yoshiko Niimura, Masahiro Kamata, Takeko Ishikawa, Mayumi Nagata, Makoto Ito, Ayu Watanabe, Shota Egawa, Hideaki Uchida, Azusa Hiura, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Yayoi Tada
308-nm excimer light is effective for palmoplantar pustulosis regardless of the presence or absence of focal infection: Single-center real-world experience of treatment for palmoplantar pustulosis. The Journal of dermatology 51 (7) (2024)
Yayoi Tada, Ahmed M Soliman, Kanako Ishii, Ryuta Sakuma, Andreas Pinter, Matthew Davis, Dominic Nunag, Marric Buessing, Luis Puig, Shinichi Imafuku
Dose escalation of biologic treatment in patients with moderate-to-severe psoriasis in Japan. Experimental dermatology 33 (5) (2024)
Yoshiko Niimura, Masahiro Kamata, Takeko Ishikawa, Mayumi Nagata, Makoto Ito, Ayu Watanabe, Shota Egawa, Hideaki Uchida, Azusa Hiura, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Yayoi Tada
308-nm excimer light is effective for palmoplantar pustulosis regardless of the presence or absence of focal infection: Single-center real-world experience of treatment for palmoplantar pustulosis. The Journal of dermatology (2024)
Yayoi Tada, Yukako Sugiura, Manami Kamishima, Yoshihito Tanaka, Hiroaki Tsuchiya, Junya Masuda, Keiichi Yamanaka
Safety and effectiveness of guselkumab in Japanese patients with psoriasis: 20-week interim analysis of a postmarketing surveillance study. The Journal of dermatology 51 (6) (2024)
Ryosuke Takeshima, Masahiro Kamata, Shoya Suzuki, Makoto Ito, Ayu Watanabe, Hideaki Uchida, Chika Chijiwa, Yoshiki Okada, Saori Azuma, Mayumi Nagata, Shota Egawa, Azusa Hiura, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Takeko Ishikawa, Yayoi Tada
Interleukin-23 inhibitors decrease Fibrosis-4 index in psoriasis patients with elevated Fibrosis-4 index but not inteleukin-17 inhibitors. The Journal of dermatology (2024)
Yukari Okubo, Tadashi Terui, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Takeshi Kimura, Junichiro Shimauchi, Wendy Zhang, Hamid Amouzadeh, Masamoto Murakami
Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study. Dermatology and therapy (2024)
Shoya Suzuki, Masahiro Kamata, Makoto Ito, Ayu Watanabe, Hideaki Uchida, Chika Chijiwa, Saori Azuma, Kotaro Hayashi, Kazumitsu Sugiura, Yayoi Tada
Spesolimab improved pustules on the palms and soles that were refractory to tumor necrosis factor inhibitors and interleukin-17 inhibitors in a patient with generalized pustular psoriasis: A case report. The Journal of dermatology (2024)
Yukari Okubo, Tadashi Terui, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Takeshi Kimura, Junichiro Shimauchi, Wendy Zhang, Hamid Amouzadeh, Masamoto Murakami
Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study. Dermatology and therapy 14 (7) (2024)
Yukari Okubo, Tadashi Terui, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Takeshi Kimura, Junichiro Shimauchi, Wendy Zhang, Hamid Amouzadeh, Masamoto Murakami
Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study. Dermatology and therapy 14 (7) (2024)
Ryosuke Takeshima, Masahiro Kamata, Shoya Suzuki, Makoto Ito, Ayu Watanabe, Hideaki Uchida, Chika Chijiwa, Yoshiki Okada, Saori Azuma, Mayumi Nagata, Shota Egawa, Azusa Hiura, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Takeko Ishikawa, Yayoi Tada
Interleukin-23 inhibitors decrease Fibrosis-4 index in psoriasis patients with elevated Fibrosis-4 index but not inteleukin-17 inhibitors. The Journal of dermatology 51 (9) (2024)
Yukari Okubo, Tadashi Terui, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Takeshi Kimura, Junichiro Shimauchi, Wendy Zhang, Hamid Amouzadeh, Masamoto Murakami
Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study. Dermatology and therapy 14 (7) (2024)
Akihiko Asahina, Yukari Okubo, Akimichi Morita, Yayoi Tada, Atsuyuki Igarashi, Richard G Langley, Delphine Deherder, Mizuho Matano, Veerle Vanvoorden, Maggie Wang, Mamitaro Ohtsuki, Hidemi Nakagawa
Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study. Dermatology and therapy 13 (3) (2023)
Tadashi Terui, Yukari Okubo, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Natsuka Uehara, Takahiro Handa, Masayuki Tanaka, Wendy Zhang, Maria Paris, Masamoto Murakami
Author Correction: Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study. American journal of clinical dermatology (2023)
Itsumi Mizukawa, Masahiro Kamata, Teruo Shimizu, Makoto Ito, Ayu Watanabe, Hideaki Uchida, Shota Egawa, Mayumi Nagata, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Takeko Ishikawa, Kazumitsu Sugiura, Yayoi Tada
Expression of interleukin-36 receptor antagonist in a patient with generalized pustular psoriasis harboring the p.Pro82Leu variant in the IL36RN gene. The Journal of dermatology (2023)
Hideaki Uchida, Masahiro Kamata, Ayu Watanabe, Makoto Ito, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Takeko Ishikawa, Yayoi Tada
Improvement of severe alopecia areata after 9-month baricitinib treatment followed by subsequent use of upadacitinib in a patient with atopic dermatitis. The Journal of dermatology (2023)
Akihiko Asahina, Yukari Okubo, Akimichi Morita, Yayoi Tada, Atsuyuki Igarashi, Richard G Langley, Delphine Deherder, Mizuho Matano, Veerle Vanvoorden, Maggie Wang, Mamitaro Ohtsuki, Hidemi Nakagawa
Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study. Dermatology and therapy 13 (3) (2023)
Akihiko Asahina, Yukari Okubo, Akimichi Morita, Yayoi Tada, Atsuyuki Igarashi, Richard G Langley, Delphine Deherder, Mizuho Matano, Veerle Vanvoorden, Maggie Wang, Mamitaro Ohtsuki, Hidemi Nakagawa
Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study. Dermatology and therapy (2023)
Akihiko Asahina, Yukari Okubo, Akimichi Morita, Yayoi Tada, Atsuyuki Igarashi, Richard G Langley, Delphine Deherder, Mizuho Matano, Veerle Vanvoorden, Maggie Wang, Mamitaro Ohtsuki, Hidemi Nakagawa
Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study. Dermatology and therapy 13 (3) (2023)
Akihiko Asahina, Yukari Okubo, Akimichi Morita, Yayoi Tada, Atsuyuki Igarashi, Richard G Langley, Delphine Deherder, Mizuho Matano, Veerle Vanvoorden, Maggie Wang, Mamitaro Ohtsuki, Hidemi Nakagawa
Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study. Dermatology and therapy (2023)
Hideaki Uchida, Masahiro Kamata, Takeko Ishikawa, Makoto Ito, Ayu Watanabe, Shota Egawa, Azusa Hiura, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Yayoi Tada
Safety and effectiveness of fosravuconazole for the treatment of onychomycosis in hemodialysis patients: A single-center retrospective study. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Tadashi Terui, Yukari Okubo, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Natsuka Uehara, Takahiro Handa, Masayuki Tanaka, Wendy Zhang, Maria Paris, Masamoto Murakami
Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study. American journal of clinical dermatology (2023)
Anthony P Fernandez, Esteban Daudén, Sascha Gerdes, M G Lebwohl, M A Menter, C L Leonardi, Melinda J Gooderham, K Gebauer, Yayoi Tada, Jean-Philippe Lacour, L Bianchi, Alexander Egeberg, I Pau-Charles, A M Mendelsohn, S J Rozzo, Nehal N Mehta
Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome: post hoc analysis of 5-year data from reSURFACE 1 and reSURFACE 2. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (10) (2022)
Hidehisa Saeki, Yasumasa Kanai, Kenta Murotani, Kei Ito, Takuya Miyagi, Hidetoshi Takahashi, Yayoi Tada, Mari Higashiyama, Yuki Hashimoto, Hiroki Kitabayashi, Shinichi Imafuku
Work productivity in real-life employed patients with plaque psoriasis: Results from the ProLOGUE study. The Journal of dermatology 49 (10) (2022)
Hideaki Uchida, Masahiro Kamata, Shota Egawa, Mayumi Nagata, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Takeko Ishikawa, Takamitsu Ohnishi, Yayoi Tada
Impact of the COVID-19 pandemic on biologic treatment in psoriasis patients: A single-center retrospective study in Japan. The Journal of dermatology 49 (6) (2022)
Ayu Watanabe, Masahiro Kamata, Teruo Shimizu, Hideaki Uchida, Emi Sakurai, Shoya Suzuki, Hideyuki Nakajima, Yoshiko Niimura, Makoto Ito, Shota Egawa, Mayumi Nagata, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Takeko Ishikawa, Yayoi Tada
Serum levels of angiogenesis-related factors in patients with psoriasis. The Journal of dermatology (2022)
Hideaki Uchida, Masahiro Kamata, Shota Egawa, Mayumi Nagata, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Takeko Ishikawa, Yayoi Tada
Newly developed erythema and red papules in the face and neck with detection of demodex during dupilumab treatment for atopic dermatitis improved by discontinuation of dupilumab, switching to upadacitinib or treatment with oral ivermectin: A report of two cases. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Makoto Ito, Masahiro Kamata, Hideaki Uchida, Shota Egawa, Mayumi Nagata, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Takeko Ishikawa, Yayoi Tada
Ixekizumab rapidly improves inflammatory markers in patients with generalized pustular psoriasis. The British journal of dermatology 187 (5) (2022)
Atsuyuki Igarashi, Hidemi Nakagawa, Akimichi Morita, Yukari Okubo, Shigetoshi Sano, Shinichi Imafuku, Yayoi Tada, Masaru Honma, Alan M Mendelsohn, Masaki Kawamura, Mamitaro Ohtsuki
Efficacy and safety of tildrakizumab in Japanese patients with moderate to severe plaque psoriasis: Results from a 64-week phase 3 study (reSURFACE 1). The Journal of dermatology 48 (6) (2021)
Kei Mukai, Masahiro Kamata, Mirei Miyazaki, Mayumi Nagata, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takeko Ishikawa, Takamitsu Ohnishi, Yayoi Tada, Takamitsu Tanaka
Edoxaban prevented adverse effects including pyrexia and elevation of D-dimer caused by the combination of BRAF and MEK inhibitors in a patient with BRAF-mutant melanoma. The Journal of dermatology 48 (5) (2021)
Hideaki Uchida, Masahiro Kamata, Mayumi Nagata, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Takeko Ishikawa, Takamitsu Ohnishi, Yayoi Tada
Baricitinib improved alopecia areata concomitant with atopic dermatitis: A case report. The Journal of dermatology 48 (9) (2021)
Atsuko Fukuyasu, Masahiro Kamata, Carren Sy Hau, Mayumi Nagata, Saki Fukaya, Kotaro Hayashi, Takamitsu Tanaka, Takeko Ishikawa, Takamitsu Ohnishi, Yayoi Tada, Naoko Kanda
Serum interleukin-10 level increases in patients with severe signs or symptoms of herpes zoster and predicts the duration of neuralgia. The Journal of dermatology 48 (4) (2021)
Yayoi Tada, L Iversen, J Koo
Early efficacy and safety data with fixed-dose combination calcipotriol/betamethasone dipropionate foam attributed to mechanism of absorption and steroid potency. Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
Shinichi Imafuku, Hidemi Nakagawa, Atsuyuki Igarashi, Akimichi Morita, Yukari Okubo, Shigetoshi Sano, Yayoi Tada, Osamu Nemoto, Stephen J Rozzo, Masaki Kawamura, Mamitaro Ohtsuki
Long-term efficacy and safety of tildrakizumab in Japanese patients with moderate to severe plaque psoriasis: Results from a 5-year extension of a phase 3 study (reSURFACE 1). The Journal of dermatology 48 (6) (2021)
Aika Kato, Masahiro Kamata, Makoto Ito, Hideaki Uchida, Mayumi Nagata, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Takeko Ishikawa, Takamitsu Ohnishi, Yayoi Tada
Higher baseline serum lactate dehydrogenase level is associated with poor effectiveness of dupilumab in the long term in patients with atopic dermatitis. The Journal of dermatology 47 (9) (2020)
Yurika Kawasaki, Masahiro Kamata, Teruo Shimizu, Mayumi Nagata, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Takeko Ishikawa, Takamitsu Ohnishi, Yayoi Tada
Thymus and activation-regulated chemokine (TARC) in patients with psoriasis: Increased serum TARC levels in patients with generalized pustular psoriasis. The Journal of dermatology 47 (10) (2020)
Yukiko Sawabe, Kotaro Hayashi, Masahiro Kamata, Mayumi Nagata, Saki Fukaya, Atsuko Fukuyasu, Takamitsu Tanaka, Takeko Ishikawa, Takamitsu Ohnishi, Hirohiko Komatsu, Masaru Tanaka, Kazumitsu Sugiura, Yayoi Tada
Case of generalized pustular psoriasis with coexisting mutations in IL36RN and CARD14. The Journal of dermatology 46 (10) (2019)
Yayoi Tada, Kanako Ishii, Junko Kimura, Keigo Hanada, Isao Kawaguchi
Patient preference for biologic treatments of psoriasis in Japan. The Journal of dermatology 46 (6) (2019)
Shuko Takeuchi, Masahiro Kamata, Hideaki Uchida, Mayumi Nagata, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Takeko Ishikawa, Takamitsu Ohnishi, Yayoi Tada
Serum infliximab level in an infant delivered from a mother with psoriatic arthritis receiving infliximab. The Journal of dermatology 47 (1) (2019)
Masahiro Kamata, Yoshihide Asano, Rino Shida, Narumi Maeda, Ayumi Yoshizaki, Tomomitsu Miyagaki, Tomohiko Kawashima, Yayoi Tada, Shinichi Sato
Secukinumab decreased circulating anti-BP180-NC16a autoantibodies in a patient with coexisting psoriasis vulgaris and bullous pemphigoid. The Journal of dermatology 46 (6) (2019)
Shintaro Takeoka, Teruo Shimizu, Masahiro Kamata, Carren Sy Hau, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Takeko Ishikawa, Takamitsu Ohnishi, Yayoi Tada
Calcipotriol and betamethasone dipropionate exhibit different immunomodulatory effects on imiquimod-induced murine psoriasiform dermatitis. The Journal of dermatology 47 (2) (2019)
H Uchida, Masahiro Kamata, I Mizukawa, A Watanabe, A Agematsu, M Nagata, S Fukaya, K Hayashi, A Fukuyasu, T Tanaka, T Ishikawa, T Ohnishi, Yayoi Tada
Real-world effectiveness and safety of dupilumab for the treatment of atopic dermatitis in Japanese patients: a single-centre retrospective study. The British journal of dermatology 181 (5) (2019)
Kaoru Namiki, Masahiro Kamata, Teruo Shimizu, Chika Chijiwa, Hideaki Uchida, Shogo Okinaga, Midori Harafuji, Mayumi Nagata, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Takeko Ishikawa, Takamitsu Ohnishi, Yayoi Tada
Thyroid dysfunction in patients with psoriasis: Higher prevalence of thyroid dysfunction in patients with generalized pustular psoriasis. The Journal of dermatology 47 (2) (2019)
Yuki Shono, Masahiro Kamata, Shintaro Takeoka, Tetsuya Ikawa, Mihoko Tateishi, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Takeko Ishikawa, Takamitsu Ohnishi, Kurumi Asako, Hajime Kono, Yayoi Tada
Cutaneous sarcoidosis in a patient with rheumatoid arthritis receiving tocilizumab. The Journal of dermatology 45 (8) (2018)
Saki Fukaya, Masahiro Kamata, Tomoko Kasanuki, Makoto Yokobori, Shintaro Takeoka, Kotaro Hayashi, Takamitsu Tanaka, Atsuko Fukuyasu, Takeko Ishikawa, Takamitsu Ohnishi, Satoshi Iimuro, Yayoi Tada, Shinichi Watanabe
Open-label pilot study to evaluate the effectiveness of topical bimatoprost on rhododendrol-induced refractory leukoderma. The Journal of dermatology 45 (11) (2018)
Shiori Komatsuda, Masahiro Kamata, Chika Chijiwa, Kaoru Namiki, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Takeko Ishikawa, Takamitsu Ohnishi, Koichiro Abe, Takatsugu Yamamoto, Naohiko Aozasa, Kazumitsu Sugiura, Yayoi Tada
Gastrointestinal bleeding with severe mucosal involvement in a patient with generalized pustular psoriasis without IL36RN mutation. The Journal of dermatology 46 (1) (2018)
Chika Chijiwa, Shintaro Takeoka, Masahiro Kamata, Mihoko Tateishi, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Takeko Ishikawa, Takamitsu Ohnishi, Shinichi Watanabe, Yayoi Tada
Decrease in eosinophils infiltrating into the skin of patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid. The Journal of dermatology 45 (5) (2018)
C Chijiwa, S Takeoka, Masahiro Kamata, H Uchida, S Fukaya, K Hayashi, A Fukuyasu, T Tanaka, T Ishikawa, T Ohnishi, Yayoi Tada
Secukinumab decreases serum Krebs von den Lungen 6 (KL-6) level in patients with psoriasis with elevated serum KL-6 level. The British journal of dermatology 179 (6) (2018)
Masahiro Kamata, Yayoi Tada
Safety of biologics in psoriasis. The Journal of dermatology 45 (3) (2017)
Maasa Kobayashi, Mayumi Nagata, Satoe Oaku, Naoko Kanda, Yayoi Tada, Naohiko Aozasa
Two cases of skin infection during psoriasis treatment with brodalumab. The Journal of dermatology 45 (3) (2017)